What is the current stock price of Regenicin, Inc. (RGIN)?

As of the latest market data, Regenicin, Inc. (RGIN) is trading at $0.00. The stock has seen a loss of 0.00% today.

Does Regenicin, Inc. (RGIN) pay a dividend?

Based on current data, Regenicin, Inc. does not have a confirmed active dividend policy.

What is the market cap of Regenicin, Inc.?

The current market capitalization of Regenicin, Inc. (RGIN) is approximately unavailable.

RGIN

Regenicin, Inc.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.75

Company Profile

Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. The company's product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. Its products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2009-11-16

Beta

-2.27

Websitewww.regenicin.com↗